Allergic conditions
Development and validation of the angiotensin-converting enzyme inhibitor (ACEI) induced angioedema investigator rating scale and proposed discharge criteria
Bonner N, Panter C, Kimura A, Sinert R, Moellman J, Bernstein J A
BMC Health Serv Res. 2017; 17: 366
Development and validation of the angiotensin-converting enzyme inhibitor (ACEI) induced angioedema investigator rating scale and proposed discharge criteria
Bonner N, Kimura A, Panter C, Sinert R, Moellman JJ, Bernstein JA
Poster session presented at: 20th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Philadelphia, PA, USA, 16-20 May 2015
The economic loss associated with nasal congestion in allergic rhinitis
Okamoto Y, Crawford B, Okuizumi K
Medicine and Drug Journal. 2014;50:3;103-111 [in Japanese]
The economic loss of allergic rhinitis associated with nasal congestion
Okamoto Y, Crawford B, Okuizumi K
Iyaku Journal (Medicine and Drug Journal) 2014, 50 (3): 103-111 [Japanese]
Development of a questionnaire to assess experience and preference of intranasal corticosteroids in patients with allergic rhinitis
Crawford B, Stanford R, Wong A, Dalal A, Bayliss M
Patient Relat Outcome Meas 2011;119
Psychometric validation of the experience with allergic rhinitis nasal spray questionnaire
Crawford B, Stanford R, Wong A, Dalal A, Bayliss M
Patient Rela Outcome Meas 2011;127